Centre of Evidence Based Dermatology

VROOM study shows that pausing methotrexate for 2 weeks boosts COVID immune response


A new study published in The Lancet finds that pausing methotrexate during COVID booster enhances the immune response in people who need to take this medicine for inflammatory conditions such as psoriasis. Co-Director of the Centre of Evidence-Based Dermatology, Hywel Williams, is an author.

View the VROOM study plain English summary.

Posted on Friday 15th July 2022

Centre of Evidence Based Dermatology

The University of Nottingham
Applied Health Research Building
University Park, Nottingham

telephone: +44 (0) 115 84 68631
email: cebd@nottingham.ac.uk